ING Group’s Cantel Medical Corporation CMD Stock Holding History

ING Group’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,570	Closed	-$449K	–	810
2019 Q2	$449K	Buy	5,570 +8	+0.1%	+$562	0.01%	545
2019 Q1	$372K	Sell	5,562 -2	-0%	-$151	0.01%	546
2018 Q4	$414K	Buy	5,564 +17	+0.3%	+$1.4K	0.01%	507
2018 Q3	$511K	Buy	5,547 +117	+2%	+$11.1K	0.01%	504
2018 Q2	$534K	Buy	+5,430	New	+$607K	0.01%	440

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ING Group's CMD Position: Q3 2019 in Review

ING Group sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 5,570 shares — an estimated $449K sold.

ING Group first reported a position in CMD in Q2 2018 and held it in 5 quarters. The position peaked at $534K in Q2 2018. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

ING Group reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
ING Group sold 5,570 Cantel Medical Corporation shares in Q3 2019, an estimated $449K.
ING Group first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 5 quarters.
ING Group's Cantel Medical Corporation position peaked at $534K in Q2 2018.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.